The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer

被引:24
|
作者
Basu, Narendra Nath [1 ,2 ]
Hodson, James [2 ]
Chatterjee, Shaunak [2 ]
Gandhi, Ashu [3 ]
Wisely, Julie [3 ]
Harvey, James [3 ]
Highton, Lyndsey [3 ]
Murphy, John [3 ]
Barnes, Nicola [3 ]
Johnson, Richard [3 ]
Barr, Lester [3 ]
Kirwan, Cliona C. [3 ]
Howell, Sacha [3 ,4 ]
Baildam, Andrew D. [3 ]
Howell, Anthony [3 ,4 ]
Evans, D. Gareth [3 ,4 ,5 ,6 ,7 ]
机构
[1] Univ Birmingham, Birmingham B15 2TT, W Midlands, England
[2] Univ Hosp Birmingham NHS Trust, Mindelsohn Way, Birmingham B15 2TH, W Midlands, England
[3] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Prevent Breast Canc Res Unit, Manchester M23 9LT, Lancs, England
[4] Christie Hosp, Manchester Breast Ctr, Manchester M20, Lancs, England
[5] Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, NW Genom Lab Hub, Manchester M13 9WL, Lancs, England
[6] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Evolut & Genom Sci,Sch Biol Sci, Manchester, Lancs, England
[7] Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Clin Genet Serv, Manchester M13 9WL, Lancs, England
关键词
D O I
10.1038/s41598-021-82654-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Contralateral risk-reducing mastectomy (CRRM) rates have tripled over the last 2 decades. Reasons for this are multi-factorial, with those harbouring a pathogenic variant in the BRCA1/2 gene having the greatest survival benefit. On May 14th, 2013, Angelina Jolie shared the news of her bilateral risk-reducing mastectomy (BRRM), on the basis of her BRCA1 pathogenic variant status. We evaluated the impact of this news on rates of CRRM in women with increased risk for developing breast cancer after being diagnosed with unilateral breast cancer. The prospective cohort study included all women with at least a moderate lifetime risk of developing breast cancer who attended our family history clinic (1987-2019) and were subsequently diagnosed with unilateral breast cancer. Rates of CRRM were then compared between patients diagnosed with breast cancer before and after Angelina Jolie's announcement (pre- vs. post-AJ). Of 386 breast cancer patients, with a mean age at diagnosis of 48 +/- 8 years, 268 (69.4%) were diagnosed in the pre-AJ period, and 118 (30.6%) in the post-AJ period. Of these, 123 (31.9%) underwent CRRM, a median 42 (interquartile range: 11-54) days after the index cancer surgery. Rates of CRRM doubled following AJ's news, from 23.9% pre-AJ to 50.0% post AJ (p<0.001). Rates of CRRM were found to decrease with increasing age at breast cancer (p<0.001) and tumour TNM stage (p=0.040), and to increase with the estimated lifetime risk of breast cancer (p<0.001) and tumour grade (p=0.015) on univariable analysis. After adjusting for these factors, the step-change increase in CRRM rates post-AJ remained significant (odds ratio: 9.61, p<0.001). The AJ effect appears to have been associated with higher rates of CRRM amongst breast cancer patients with increased cancer risk. CRRM rates were highest amongst younger women and those with the highest lifetime risk profile. Clinicians need to be aware of how media news can impact on the delivery of cancer related services. Communicating objective assessment of risk is important when counselling women on the merits of risk-reducing surgery.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Risk-reducing mastectomy for the prevention of primary breast cancer
    Carbine, Nora E.
    Lostumbo, Liz
    Wallace, Judi
    Ko, Henry
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (04):
  • [22] Breast cancer after bilateral risk-reducing mastectomy
    Skytte, A-B
    Cruger, D.
    Gerster, M.
    Laenkholm, A-V
    Lang, C.
    Brondum-Nielsen, K.
    Andersen, M. K.
    Sunde, L.
    Kolvraa, S.
    Gerdes, A-M
    CLINICAL GENETICS, 2011, 79 (05) : 431 - 437
  • [23] Breast Cancer And The "Angelina Jolie Effect" - Trends in Breast Cancer Related Internet Searches
    Rahmani, G.
    Joyce, C.
    Kelly, J.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S327 - S327
  • [24] Risk-Reducing Mastectomy
    Jatoi, Ismail
    Kemp, Zoe
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (17): : 1781 - 1782
  • [25] Risk-reducing mastectomy
    Chiesa, Federica
    Sacchini, Virgilio S.
    MINERVA GINECOLOGICA, 2016, 68 (05): : 544 - 547
  • [26] Has the Angelina Jolie effect led to an increase in risk reducing mastectomy and breast reconstruction in Wales: A retrospective, single centre cohort study
    Malcolm, Cathy M.
    Javed, Muhammad Umair
    Dai Nguyen
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2016, 69 (02): : 288 - 289
  • [27] Decision-making for bilateral risk-reducing mastectomy for an increased lifetime breast cancer risk: A qualitative metasynthesis
    Torrisi, Christa
    Wareg, Nuha K.
    Anbari, Allison Brandt
    PSYCHO-ONCOLOGY, 2024, 33 (03)
  • [28] Contralateral risk reducing mastectomy in patients with sporadic breast cancer. Benefits and hazards
    Boccardo, C.
    Gentilini, O.
    EJSO, 2016, 42 (07): : 913 - 918
  • [29] Contralateral risk-reducing (prophylactic) mastectomy (RRM) in patients (pts) with breast cancer (BC): Experience at Mastologica Lomas Breast Center in Mexico City
    Sanchez-Forgach, E. R.
    Sanchez Basurto, C.
    Zabalaga, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [30] Surgical Outcome Measures in a Cohort of Patients at High Risk of Breast Cancer Treated by Bilateral Risk-Reducing Mastectomy and Breast Reconstruction
    Gandhi, Ashu
    Duxbury, Paula
    Clancy, Tara
    Lalloo, Fiona
    Wisely, Julie A.
    Kirwan, Cliona C.
    Foden, Philip
    Stocking, Katie
    Howell, Anthony
    Evans, D. Gareth
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2022, 150 (03) : 496E - 505E